PRRT in high‐grade digestive neuroendocrine neoplasms (NET G3 and NEC)
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Neuroendocrinology"
DOI: 10.1111/jne.13443
Abstract: Peptide receptor radionuclide therapy (PRRT) has been primarily studied in low and intermediate‐grade digestive neuroendocrine tumors (NET G1‐G2). The documentation of a similar benefit for high‐grade digestive neuroendocrine neoplasms (NEN) has been limited. This review… read more here.
Keywords: high grade; grade digestive; grade; prrt ... See more keywords